These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 27352979)

  • 1. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease.
    Corona JC; Duchen MR
    Free Radic Biol Med; 2016 Nov; 100():153-163. PubMed ID: 27352979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides.
    Singh K; Gupta JK; Kumar S; Soni U
    Curr Protein Pept Sci; 2024; 25(7):507-526. PubMed ID: 38561605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria: a therapeutic target in neurodegeneration.
    Moreira PI; Zhu X; Wang X; Lee HG; Nunomura A; Petersen RB; Perry G; Smith MA
    Biochim Biophys Acta; 2010 Jan; 1802(1):212-20. PubMed ID: 19853657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ and PGC-1α as therapeutic targets in Parkinson's.
    Corona JC; Duchen MR
    Neurochem Res; 2015 Feb; 40(2):308-16. PubMed ID: 25007880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol: A Focus on Several Neurodegenerative Diseases.
    Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
    Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
    Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents.
    Kaundal RK; Sharma SS
    Drug News Perspect; 2010 May; 23(4):241-56. PubMed ID: 20520853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases.
    Stanga S; Caretto A; Boido M; Vercelli A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q treatment of neurodegenerative diseases of aging.
    Galpern WR; Cudkowicz ME
    Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoid-based therapies in the early management of neurodegenerative diseases.
    Solanki I; Parihar P; Mansuri ML; Parihar MS
    Adv Nutr; 2015 Jan; 6(1):64-72. PubMed ID: 25593144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.